Restore Vision Inc., a clinical-stage biotechnology company advancing gene therapies for retinal disorders, today announced the interim clinical results from its ongoing Phase 1/2 first-in-human trial ...

UC Santa Barbara researchers and collaborators from campus biotech spinoff Integrated Biosciences, as well as Harvard, MIT, Princeton and genomics company Illumina Ventures are using optogenetics — ...

A KAIST research team led by Professor Won Do Heo (Department of Biological Sciences) has developed an optogenetic platform, RELISR (REversible LIght-induced Store and Release), that enables precise ...

Fermeate, an industrial biotechnology company developing optogenetic control for industrial-scale precision fermentation, today announced a successful $2 million Seed round led by Newfund Capital with ...

A landmark study published in Cell has unveiled a first-of-a-kind optogenetic screening platform, developed by scientists at Integrated Biosciences, a biotechnology company integrating optogenetics, ...

Designated areas (white circles) were irradiated with blue light at specific frequencies (indicated in the top left of each panel) to examine chemotactic aggregation. A research team led by Dr.

One of the hallmarks of cancer cells is their ability to evade apoptosis, or programmed cell death, through changes in protein expression. Inducing apoptosis in cancer cells has become a major focus ...

Please provide your email address to receive an email when new articles are posted on . The trial, which included 27 participants, met its safety and efficacy endpoints at 52 weeks and 76 weeks. The ...

An optogenetic effect, like domino-toppling extravaganza, requires careful preparation. It also presents a chain-reaction sequence of events that may end all too soon. At least with dominoes, the ...